Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-03-03 to 2023-03-06
Current total value of award: $2294.52
Description: 4560130850!QUILLIVANT XR ORAL SUSP 180ML 5MG/ML